1.15
price down icon5.74%   -0.07
after-market Handel nachbörslich: 1.11 -0.04 -3.48%
loading

Finanzdaten der Cocrystal Pharma Inc-Aktie (COCP)

Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30
Periodenlänge 3 Monate 3 Monate 3 Monate 3 Monate 3 Monate
Revenues
-
- - - -
Operating Expenses
9.95%
2.108
2.341 3.23 5.042 5.448
Depreciation and Amortization
16.00%
0.021
0.025 0.028 0.03 0.033
Operating Income/Loss
9.95%
-2.108
-2.341 -3.23 -5.042 -5.448
Nonoperating Income/Loss
32.50%
0.053
0.04 -0.036 0.103 0.105
Income/Loss From Continuing Operations Before Tax
10.69%
-2.055
-2.301 -3.266 -4.939 -5.343
Income/Loss From Continuing Operations After Tax
10.69%
-2.055
-2.301 -3.266 -4.939 -5.343
Net Income/Loss
10.69%
-2.055
-2.301 -3.266 -4.939 -5.343
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
0.00%
10.17
10.17 - 10.17 10.17
Diluted Average Shares
0.00%
10.17
10.17 - 10.17 10.17
Basic Earnings Per Share
13.04%
-0.20
-0.23 -0.32 -0.49 -0.53
Diluted Earnings Per Share
13.04%
-0.20
-0.23 -0.32 -0.49 -0.53
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$21.35
price down icon 5.74%
$83.80
price down icon 1.12%
$31.81
price down icon 0.13%
$102.06
price down icon 2.32%
$162.33
price down icon 1.26%
biotechnology ONC
$320.10
price down icon 4.68%
Kapitalisierung:     |  Volumen (24h):